Type(s) of Cancer
Prostate
Prostate
Study Phase
Phase 3
Study Completion Date
December 2011
December 2011
NCT00676650Uploaded 09-09-2013
Available for Download
PDS UID: Prostat_Pfizer_2008_81
A Multicenter, Randomized, Double-Blind, Phase 3 Study Of Sunitinib Plus Prednisone Versus Prednisone In Patients With Progressive Metastatic Castration-Resistant Prostate Cancer After Failure Of A Docetaxel-Based Chemotherapy Regimen
Files:
PROTOCOLPfizer Study Protocol Sunitinib.pdf
CRFPfizer CRF Sunitinib.pdf
DATA DICTIONARYPfizer Data Descriptors Sunitinib.xlsx
DATA (COMPARATOR ARM)Pfizer Data Sunitinib.zip